Biotech Corbus Pharmaceuticals News Portfolio

Corbus Pharmaceuticals Presents Phase 2 OLE Data for Lenabasum: Is This Stock a Buy Now?

Biotech News | 11.11.2019

Corbus Pharmaceuticals today presented the open-label-extension (OLE) data from its two phase 2...